Literature DB >> 22718214

Clinical stability versus clinical failure in patients with community-acquired pneumonia.

Stefano Aliberti1, Francesco Blasi.   

Abstract

Once antibiotics have been started in patients with community-acquired pneumonia (CAP), the evaluation of clinical outcomes represents one of the essential steps in patient care. Among CAP patients who improve, recognition of clinical stability should be based on both subjective and objective parameters that are locally available in the everyday clinical practice. Different steps in the management of the pneumonia depend on this early outcome, including the switch from intravenous to oral antibiotics, patients' discharge from the hospital, and outcomes after hospitalization. When deterioration occurs in CAP patients, a "treatment failure" or a "clinical failure" should be identified. It is crucial to understand the etiology of failure so as to develop different measures at both international and local levels to prevent adverse outcomes. Finally, several efforts should be made to define incidence, timing, and risk factors for nonresolving pneumonia that, to date, remains one of the most indeterminate clinical outcomes in patients with CAP. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718214     DOI: 10.1055/s-0032-1315640

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  4 in total

1.  Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study.

Authors:  Francesco Blasi; Helmut Ostermann; Jill Racketa; Jesús Medina; Kyle McBride; Javier Garau
Journal:  Respir Res       Date:  2014-01-22

Review 2.  Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease.

Authors:  Helen C Steel; Riana Cockeran; Ronald Anderson; Charles Feldman
Journal:  Mediators Inflamm       Date:  2013-12-25       Impact factor: 4.711

3.  The efficacy of high-dose penicillin G for pneumococcal pneumonia diagnosed based on initial comprehensive assessment at admission: an observational study.

Authors:  Junpei Komagamine
Journal:  BMC Res Notes       Date:  2018-06-20

Review 4.  Community-acquired pneumonia.

Authors:  Elena Prina; Otavio T Ranzani; Antoni Torres
Journal:  Lancet       Date:  2015-08-12       Impact factor: 79.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.